Move follows report by food safety agency on health risks to bees

More than 16,000 people showed up to the meeting in New Orleans. Here are a few of their stories

Theoretical model uses readily available data to predict catalysts for tackling energy challenges

Using a multitude of methods, chemists make unprecedented crowded alkyl amines; but one elusive target remains out of reach

BASF will buy agrochemical and seed businesses for $2 billion

Key enzymes in complex biosynthesis could enable alkaloid production

Flexible, lightweight skin is equipped with sensors, memory, and communications features

German chemical maker seeks to balance technical support and basic R&D that can open new markets

Sales rise as the new firm with 2 old names leads the ranking

As wildfires increase in frequency across the globe, researchers hunt the smoke compounds that can seep into vineyards’ grapes and taint wine

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it

Combining expansion microscopy and STED improves resolution 30-fold relative to the diffraction limit

Manganese phthalocyanine catalyst shows preference for least-hindered benzylic C–H bonds

Engineered bacteria could be used for bioremediation of antibiotic-contaminated soils

Natural ingredients play spices up flavor and fragrance sector

Protecting coral reefs is the legislation’s goal

Loud blasts, such as those from roadside bombs, can cause damaging fluid buildup in inner ear, according to study in mice

‘Brain gain’ program brings high-profile international researchers to Canadian universities

Cosmetics firms appeal to plastic-free consumers with the hybrid of bar soap and liquid body wash

The startup raised $40 million to target a class of GPCRs called Mas-related G-protein receptors, to treat neuroimmune and inflammatory conditions

Chemists are designing better methods to analyze confiscated nuclear materials and to track nuclear activity remotely

If successful, the transaction could spur more M&A among major drug firms